Use of Rainbow Acoustic Monitoring in Pediatric Patients - A Clinical Engineering Data Collection Protocol
1 other identifier
interventional
170
1 country
1
Brief Summary
The study will capture high resolution waveform data and numerical data from three respiratory rate methods: end tidal CO2, impedance pneumography, and bioacoustic sensing (Rainbow Acoustic Monitoring, RAM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable surgery
Started Aug 2011
Longer than P75 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2015
CompletedFirst Submitted
Initial submission to the registry
April 14, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedOctober 22, 2018
October 1, 2018
3.5 years
April 14, 2017
October 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of RAM sensor to detect respiration rate
Accuracy will be determined by comparing the noninvasive respiratory rate measurement of the sensor to that obtained from a reference and calculating the arithmetic root mean square (Arms) error value.
1-6 hours
Study Arms (1)
Test Subjects
EXPERIMENTALAll test subjects were pediatric patients following general anesthesia who received the RAM sensor which measures respiration rate.
Interventions
Eligibility Criteria
You may qualify if:
- to 18 years old inclusive, male and female patients
- Only patients with written informed consent signed by parents or legal guardians will be enrolled
- In children 10 and older, patient's assent will be obtained
You may not qualify if:
- Patients who are unable to give their consent and/or assent
- Patients with skin abnormalities (rash, eczema, etc) at the planned application sites that would interfere with sensor, cannula or electrode applications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Medical Center Dallas
Dallas, Texas, 75235, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2017
First Posted
April 25, 2017
Study Start
August 4, 2011
Primary Completion
January 20, 2015
Study Completion
July 24, 2015
Last Updated
October 22, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share